The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Åke Borg

Åke Borg

Principal investigator

Åke Borg

Chromosomal translocations involving 11q13 contribute to cyclin D1 overexpression in squamous cell carcinoma of the head and neck

Author

  • Jan Åkervall
  • Åke Borg
  • Michael Dictor
  • Charlotte Jin
  • Yuesheng Jin
  • Minna Tanner
  • Jorma Isola
  • Fredrik Mertens
  • Johan Wennerberg

Summary, in English

CCND1 amplification results in cyclin D1 overexpression. However, other unidentified genetic mechanisms contribute to enhanced gene expression. In the present study, 32 squamous cell carcinoma of the head and neck (SCCHN) were investigated regarding chromosomal abnormalities involving 11q13 by cytogenetic analysis, genomic CCND1 amplification by differential PCR and FISH, and cyclin D1 expression on the mRNA and protein level by differential RT-PCR and immunohistochemistry, respectively. CCND1 amplification, observed in 11 of 32 (34%) tumours, resulted in overexpression of cyclin D1 on the mRNA and/or protein level, in 3 cases in association with chromosomal translocations. In cytogenetic analysis, 4 tumours had hsr(11)(q13), all of which showed CCND1 amplification and cyclin D1 overexpression. Overexpression of cyclin D1 was detected at the mRNA level in 23 tumours (72%) and on the protein level in 25 tumours (78%). In one case a translocation was seen together with cyclin D1 overexpression on the mRNA level, without any cytogenetic or molecular signs of amplification. Furthermore, cases with cyclin D1 overexpression were frequently observed in the absence of any genomic rearrangement. We conclude that, besides amplifications, chromosomal translocations and other transcriptional or translational regulatory mechanisms are involved in CCND1 deregulation.

Department/s

  • Otorhinolaryngology (Lund)
  • Breastcancer-genetics
  • Tumor microenvironment
  • Division of Clinical Genetics

Publishing year

2002-01

Language

English

Pages

45-52

Publication/Series

International Journal of Oncology

Volume

20

Issue

1

Document type

Journal article

Publisher

Spandidos Publications

Topic

  • Cancer and Oncology

Keywords

  • Biopsy
  • Carcinoma, Squamous Cell
  • Chromosomes, Human, Pair 11
  • Cyclin D1
  • DNA Primers
  • Head and Neck Neoplasms
  • Humans
  • In Situ Hybridization, Fluorescence
  • Neoplasm Proteins
  • Paraffin Embedding
  • Polymerase Chain Reaction
  • RNA, Messenger
  • Translocation, Genetic
  • Tumor Cells, Cultured
  • Journal Article
  • Research Support, Non-U.S. Gov't

Status

Published

ISBN/ISSN/Other

  • ISSN: 1019-6439